Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon

dc.contributor.authorY Almawi, Wassim
dc.contributor.authorWakim-Ghorayeb, Saria F
dc.contributor.authorArekat, Mona R
dc.contributor.authorNajm, Pierre
dc.contributor.authorETAL.
dc.date.accessioned2022-03-28T12:27:36Z
dc.date.accessioned2023-08-19T08:56:56Z
dc.date.available2022-03-28T12:27:36Z
dc.date.available2023-08-19T08:56:56Z
dc.date.issued2006-11
dc.description.abstractThe association of HLA class II with type 2 diabetes (T2DM) was investigated in Bahraini and Lebanese subjects. DRB1*070101 (Lebanese and Bahraini) and DQB1*0201 (Lebanese) were susceptibility-conferring alleles, and unique susceptibility-conferring/protective haplotypes were found in both patient groups. Regression analysis confirmed that DRB1*070101-DQB1*0201 (Bahraini) and DRB1*110101-DQB1*0201 (Lebanese) were susceptibility-conferring haplotypes.en_US
dc.identifier.citationAlmawi, W. Y., Wakim-Ghorayeb, S. F., Arekat, M. R., Najm, P., Keleshian, S. H., Al-Sayed, N., ... & Irani-Hakime, N. (2006). Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon. Clinical and vaccine immunology, 13(11), 1296-1298.en_US
dc.identifier.doihttps://doi.org/10.1128/CVI.00206-06
dc.identifier.urihttps://edms.wexl.in/handle/1/3031
dc.language.isoenen_US
dc.publisherAmerican Society for Microbiologyen_US
dc.subjectDiabetes mellitusen_US
dc.subjectType 2 diabetesen_US
dc.subjectLebaneseen_US
dc.subjectHLAen_US
dc.titleAssociation of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanonen_US
dc.title.alternativeClinical and vaccine immunologyen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:

Collections